Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
microliter 34 44 34 44 I-lower_bound

Creatinine 0 10 45 55 B-clinical_variable
within 11 17 56 62 O
normal 18 24 63 69 O
institutional 25 38 70 83 O
limits 39 45 84 90 O
or 46 48 91 93 O
creatinine 49 59 94 104 B-clinical_variable
clearance 60 69 105 114 I-clinical_variable
> 70 71 115 116 O
60 72 74 117 119 B-lower_bound
mL 75 77 120 122 I-lower_bound
/ 77 78 122 123 I-lower_bound
min/1.73 78 86 123 131 I-lower_bound
m2 87 89 132 134 I-lower_bound
for 90 93 135 138 O
subjects 94 102 139 147 O
with 103 107 148 152 O
creatinine 108 118 153 163 B-clinical_variable
levels 119 125 164 170 I-clinical_variable
about 126 131 171 176 O
institutional 132 145 177 190 O
normal 146 152 191 197 O

HIV 0 3 198 201 B-chronic_disease
- 3 4 201 202 O
positive 4 12 202 210 O
individuals 13 24 211 222 O
on 25 27 223 225 O
combination 28 39 226 237 O
antiretroviral 40 54 238 252 B-treatment
therapy 55 62 253 260 I-treatment
are 63 66 261 264 O
ineligible 67 77 265 275 O
because 78 85 276 283 O
of 86 88 284 286 O
the 89 92 287 290 O
potential 93 102 291 300 O
for 103 106 301 304 O
pharmacokinetic 107 122 305 320 O
interactions 123 135 321 333 O
with 136 140 334 338 O
temozolomide 141 153 339 351 B-treatment

History 0 7 352 359 O
of 8 10 360 362 O
allergic 11 19 363 371 O
reactions 20 29 372 381 O
attributed 30 40 382 392 O
to 41 43 393 395 O
compounds 44 53 396 405 O
of 54 56 406 408 O
similar 57 64 409 416 O
chemical 65 73 417 425 O
or 74 76 426 428 O
biologic 77 85 429 437 O
composition 86 97 438 449 O
to 98 100 450 452 O
temozolomide 101 113 453 465 B-allergy_name

Individuals 0 11 466 477 O
with 12 16 478 482 O
a 17 18 483 484 O
history 19 26 485 492 O
of 27 29 493 495 O
other 30 35 496 501 O
malignancies 36 48 502 514 B-cancer
are 49 52 515 518 O
eligible 53 61 519 527 O
if 62 64 528 530 O
they 65 69 531 535 O
have 70 74 536 540 O
been 75 79 541 545 O
disease 80 87 546 553 O
- 87 88 553 554 O
free 88 92 554 558 O
for 93 96 559 562 O
at 97 99 563 565 O
least 100 105 566 571 O
3 106 107 572 573 B-lower_bound
years 108 113 574 579 I-lower_bound
and 114 117 580 583 O
are 118 121 584 587 O
deemed 122 128 588 594 O
by 129 131 595 597 O
the 132 135 598 601 O
investigator 136 148 602 614 O
to 149 151 615 617 O
be 152 154 618 620 O
at 155 157 621 623 O
low 158 161 624 627 O
risk 162 166 628 632 O
for 167 170 633 636 O
recurrence 171 181 637 647 O
of 182 184 648 650 O
that 185 189 651 655 O
malignancy 190 200 656 666 B-cancer

Individuals 0 11 667 678 O
with 12 16 679 683 O
the 17 20 684 687 O
following 21 30 688 697 O
cancers 31 38 698 705 B-cancer
are 39 42 706 709 O
eligible 43 51 710 718 O
if 52 54 719 721 O
diagnosed 55 64 722 731 O
and 65 68 732 735 O
treated 69 76 736 743 O
within 77 83 744 750 O
the 84 87 751 754 O
past 88 92 755 759 B-upper_bound
5 93 94 760 761 I-upper_bound
years 95 100 762 767 I-upper_bound
: 100 101 767 768 O
cervical 102 110 769 777 B-cancer
cancer 111 117 778 784 I-cancer
in 118 120 785 787 I-cancer
situ 121 125 788 792 I-cancer
, 125 126 792 793 O
and 127 130 794 797 O
basal 131 136 798 803 B-cancer
cell 137 141 804 808 I-cancer
or 142 144 809 811 O
squamous 145 153 812 820 B-cancer
cell 154 158 821 825 I-cancer
carcinoma 159 168 826 835 I-cancer
of 169 171 836 838 I-cancer
the 172 175 839 842 I-cancer
skin 176 180 843 847 I-cancer

Karnofsky 0 9 848 857 B-clinical_variable
performance 10 21 858 869 I-clinical_variable
status 22 28 870 876 I-clinical_variable
> 29 30 877 878 O
60 31 33 879 881 B-lower_bound
( 34 35 882 883 O
ECOG 35 39 883 887 B-clinical_variable
< 40 41 888 889 O
2 42 43 890 891 B-upper_bound
) 43 44 891 892 O

Leukocytes 0 10 893 903 B-clinical_variable
> 11 12 904 905 O
3,000 13 18 906 911 B-lower_bound
/ 18 19 911 912 I-lower_bound
microliter 19 29 912 922 I-lower_bound

Participants 0 12 923 935 O
may 13 16 936 939 O
not 17 20 940 943 O
have 21 25 944 948 O
had 26 29 949 952 O
chemotherapy 30 42 953 965 B-treatment
wafer 43 48 966 971 I-treatment
placement 49 58 972 981 I-treatment
at 59 61 982 984 O
surgery 62 69 985 992 B-treatment

Participants 0 12 993 1005 O
must 13 17 1006 1010 O
be 18 20 1011 1013 O
> 21 22 1014 1015 O
70 23 25 1016 1018 B-lower_bound
years 26 31 1019 1024 I-lower_bound
of 32 34 1025 1027 O
age 35 38 1028 1031 B-age

Participants 0 12 1032 1044 O
must 13 17 1045 1049 O
have 18 22 1050 1054 O
histologically 23 37 1055 1069 O
confirmed 38 47 1070 1079 O
glioblastoma 48 60 1080 1092 B-cancer
/ 60 61 1092 1093 O
gliosarcoma 61 72 1093 1104 B-cancer

Participants 0 12 1105 1117 O
must 13 17 1118 1122 O
have 18 22 1123 1127 O
life 23 27 1128 1132 B-clinical_variable
expectancy 28 38 1133 1143 I-clinical_variable
greater 39 46 1144 1151 O
than 47 51 1152 1156 O
6 52 53 1157 1158 B-lower_bound
months 54 60 1159 1165 I-lower_bound

Participants 0 12 1166 1178 O
must 13 17 1179 1183 O
not 18 21 1184 1187 O
have 22 26 1188 1192 O
had 27 30 1193 1196 O
any 31 34 1197 1200 O
prior 35 40 1201 1206 B-treatment
therapy 41 48 1207 1214 I-treatment
for 49 52 1215 1218 O
glioblastoma 53 65 1219 1231 B-cancer
multiforme 66 76 1232 1242 I-cancer
including 77 86 1243 1252 O
radiation 87 96 1253 1262 B-treatment
or 97 99 1263 1265 O
chemotherapy 100 112 1266 1278 B-treatment

Platelets 0 9 1279 1288 B-clinical_variable
> 10 11 1289 1290 O
100,000 12 19 1291 1298 B-lower_bound
/ 19 20 1298 1299 I-lower_bound
microliter 20 30 1299 1309 I-lower_bound

Total 0 5 1310 1315 B-clinical_variable
bilirubin 6 15 1316 1325 I-clinical_variable
within 16 22 1326 1332 I-clinical_variable
normal 23 29 1333 1339 I-clinical_variable
institutional 30 43 1340 1353 I-clinical_variable
limits 44 50 1354 1360 I-clinical_variable
12 51 53 1361 1363 I-clinical_variable

Tumor 0 5 1364 1369 B-cancer
o6 6 8 1370 1372 B-clinical_variable
- 8 9 1372 1373 I-clinical_variable
methylguanine 9 22 1373 1386 I-clinical_variable
- 22 23 1386 1387 I-clinical_variable
DNA 23 26 1387 1390 I-clinical_variable
- 26 27 1390 1391 I-clinical_variable
methyltransferase 27 44 1391 1408 I-clinical_variable
promoter 45 53 1409 1417 I-clinical_variable
methylation 54 65 1418 1429 I-clinical_variable
status 66 72 1430 1436 I-clinical_variable
must 73 77 1437 1441 O
be 78 80 1442 1444 O
determined 81 91 1445 1455 O

aspartate 0 9 1456 1465 B-clinical_variable
aminotransferase 10 26 1466 1482 I-clinical_variable
test(SGOT)/alanine 27 45 1483 1501 I-clinical_variable
aminotransferase 46 62 1502 1518 I-clinical_variable
test(SGPT 63 72 1519 1528 I-clinical_variable
) 72 73 1528 1529 I-clinical_variable
< 74 75 1530 1531 O
2.5 76 79 1532 1535 B-upper_bound
X 80 81 1536 1537 I-upper_bound
institutional 82 95 1538 1551 I-upper_bound
upper 96 101 1552 1557 I-upper_bound
limit 102 107 1558 1563 I-upper_bound
of 108 110 1564 1566 I-upper_bound
normal 111 117 1567 1573 I-upper_bound

